Alosetron in irritable bowel syndrome.
McColl
K E
KE
D002243:Carbolines / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy* / Q000523:psychology; D003248:Constipation / Q000139:chemically induced; D005260:Female; D006801:Humans; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D015203:Reproducibility of Results; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D016896:Treatment Outcome
D002243:Carbolines; D012702:Serotonin Antagonists; C090840:alosetron